eNauka - pregled
Pregled prema Autor Fabri, Milotka J
Prikaz rezultata 1 do 11 od 11
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2017 | Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin - A prospective study | Ruzic, Maja   ; Fabri, Milotka J; Medic-Stojanoska, Milica K; Bajkin, Ivana A; Turkulov, Vesna; Abenavoli, Ludovico | Naučni članak | 23M23 - Rad u međ. časopisu |
| 2012 | Efficacy and Safety of Tenofovir DF (TDF) in Chronic Hepatitis B Virus Infected Patients with Documented Lamivudine Resistance (LAM-R) | Fung, SC; Kwan, Peter; Fabri, Milotka J; Horban, Andrzej; Pelemis, Mijomir R; Husa, P; Hann, Hie-Won; Flaherty, John F; Massetto, Benedetto; Dinh, Phillip;
Corsa, Amoreena C; Kitrinos, Kathryn M; McHutchison, John G; Gane, E;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2009 | Exercise induced rhabdomyolysis | Ruzic, Maja ; Fabri, Milotka J; Pobor, Marta; Jovelic, Aleksandra S ; Lukac, Damir D | Naučni članak | 24M24 - Rad u nac. časopisu međ. značaja |
| 2018 | Hepatitis C virus-induced hepatocellular carcinoma: a narrative review | Ruzic, Maja ; Pellicano, Rinaldo; Fabri, Milotka J; Luzza, Francesco; Boccuto, Luigi; Brkic, Snezana V ; Abenavoli, Ludovico | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |
| 2015 | Long Term Efficacy and Safety of Tenofovir DF (TDF) in Chronic Hepatitis B Patients (CHB) with Documented Lamivudine Resistance (LAM-R): 5 Year Results From a Randomized, Controlled Trial | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 15) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2014 | Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 16) | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
| 2010 | Rapamycin as Rescue Therapy for Rapid Progressive Hepatits C after Liver Transplantation | Maravic-Stojkovic, Vera R; Hajdukovic, Dana; Urosevic, Ivana M; Fabri, Milotka J; Calija, Branko M; Erdeljan, Svetlana; Milosevic, Zoran P | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2016 | RG-101 in Combination with 4 Weeks of Oral Direct Acting Antiviral Therapy Achieves High SVR Rates in Treatment Naive Genotype 1 and 4 Chronic Hepatitis C Patients | Horvath, Gabor; ...; Fabri, Milotka J; ...; Delic, Dragan S; ...; Rankovic, Zarko; ...; (broj, koautora 16) | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2013 | Tenofovir Df (Tdf) Is Safe and Well Tolerated in Chronic Hepatitis B (Chb) Patients with Pre-Existing Mild Renal Impairment | Fung, S; Kwan, Peter; Horban, A; Pelemis, Mijomir R; Husa, P; Hann, HW; Flaherty, John F; Massetto, Benedetto; Dinh, Phillip; Custodio, J;
Subramanian, GM; Fabri, Milotka J; Gane, E;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2017 | Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study | Fung, Scott; ...; Fabri, Milotka J; ...; Pelemis, Mijomir R; ...; (broj, koautora 22) | Naučni članak | 21aM21a - Rad u međ. časopisu izuzetnih vrednosti |
| 2019 | Validity of hepatitis B and hepatitis C case definitions | Dakic, Zoran; Duric, Predrag B; Fabri, Milotka J; O'May, Fiona | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |